Clinical Distribution and Drug Resistance of Carbapenem-resistant Acinetobacter Baumannii

Linlin WANG,Mengying WU,Mei ZHAO,Gang LI,Wei JIA

DOI: https://doi.org/10.16050/j.cnki.issn1674-6309.2016.08.013

2016-01-01

Abstract:Objective To investigate the clinical distribution and drug resistance of pathogens of carbapenem-resistant A cinetobacter baumannii (CRAB)isolated from our hospital from 2011 to 2012 and to provide the basis for reasonably selecting antibiotics.Methods The automatic detection machine of VITEK-2 compact was used for identification of bacteria. The drug susceptibility of the bacteria was performed by using disc agar diffusion(K-B method). All data were analyzed by WHONET 5.6.Results From 2011 to 2012,2284 strains of AB were detected in our hospital and 1382 strains were carbapenem-resistant CRAB,which accounted for 59.9%. A total of 80% isolates were from the respiratory tract specimens.The AB was mainly isolated from the department of intensive care unit(ICU),neurosurgery,emergency and pneumology. Drug resistances of CRAB to most Antibiotics were over 90%. CRAB had a high sensitivity to polymyxin band minocycline. Conlusion CRAB had a higher detection rate in infected patient specimens in our hospital.The strains had widespread resistance.The polymyxin B,minomycin and amikacin with considerable antibacterial activities may be the choices forcarbapenem resistant isolates infections of AB.